Clinical Evidence
254 results
HDx therapy enabled by Theranova
Extracorporeal Removal of Myoglobin in Patients with Rhabdomyolysis and Acute Kidney Injury: Comparison of High and Medium Cut-Off Membrane and an Adsorber Cartridge
HDx therapy enabled by Theranova
Extracorporeal Techniques in End-Stage Kidney Disease
HDx therapy enabled by Theranova
Flow Dynamic Analysis by Contrast-Enhanced Imaging Techniques of Medium Cutoff Membrane Hemodialyzer.
HDx therapy enabled by Theranova
Fluctuations in Interleukin-6 Levels during Hemodialysis Sessions with Medium Cutoff Membranes: An Analysis on COVID-19 Case Series
HDx therapy enabled by Theranova
From old uraemic toxins to new uraemic toxins: place of 'omics'
PD
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS) - Marshall J, et al.
HDx therapy enabled by Theranova
Health Economic Evaluation of the Theranova 400 Dialyzer Among Hemodialysis Patients in the United States: Results from a Randomized-Controlled Trial
PD
Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis - Kutner NG, et al.
HDx therapy enabled by Theranova
Hemodiafiltration (HDF) versus expanded hemodialysis (HDx)
HDx therapy enabled by Theranova
High-Flux versus High-Retention-Onset Membranes: In vivo Small and Middle Molecules Kinetics in Convective Dialysis Modalities - Cordeiro ISF et al.
HDx therapy enabled by Theranova
High-volume online haemodiafiltration treatment and outcome of end-stage renal disease patients: more than one mode.
Vantive is a trademark of Vantive Health LLC or its affiliates.